PHILADELPHIA — Gastrointestinal (GI) bleeding after percutaneous coronary intervention (PCI) among patients on dual antiplatelet therapy (DAPT) remains risky in terms of morbidity and mortality, but ...
"This study suggests that the ARC-HBR and PRECISE-DAPT bleeding criteria can be used to risk stratify patients and guide the therapeutic selection to lower the bleeding risk. For instance, we found ...
Two scores widely used to determine whether patients are at high risk for bleeding after coronary stenting disagreed in 22% of patients, and one score underestimated the risk, warned investigators ...
Patients with acute MI who experience nuisance bleeds in the first month post-PCI after going on ticagrelor-based dual antiplatelet therapy (DAPT) are more apt to then have more-severe bleeding events ...
Long-term dual antiplatelet therapy (DAPT) reduces ischemic events without a trade-off in bleeding compared with shorter durations among ACS patients who undergo PCI, according to new registry data ...
BOSTON - Nearly 1 million people in the United States receive coronary artery stents each year. Nearly all stent patients are expected to take dual antiplatelet therapy (DAPT) using the combination of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results